CAZZANIGA GIOVANNI

Ruolo: 
Ricercatore a tempo determinato
Settore scientifico disciplinare: 
GENETICA MEDICA (MED/03)

Pubblicazioni

  • Cazzola, A., Cazzaniga, G., Biondi, A., Meneveri, R., Brunelli, S., & Azzoni, E. (2021). Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 8 [10.3389/fcell.2020.618164]. Dettaglio
  • Stutterheim, J., van der Sluis, I., de Lorenzo, P., Alten, J., Ancliffe, P., Attarbaschi, A., et al. (2021). Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol. JOURNAL OF CLINICAL ONCOLOGY, 39(6 (20 February 2021)), 652-662 [10.1200/JCO.20.02333]. Dettaglio
  • Della Starza, I., Nunes, V., Lovisa, F., Silvestri, D., Cavalli, M., Garofalo, A., et al. (2021). Droplet Digital PCR Improves IG-/TR-based MRD Risk Definition in Childhood B-cell Precursor Acute Lymphoblastic Leukemia. HEMASPHERE, 5(3 ( March 2021)). Dettaglio
  • Fazio, G., Bardini, M., De Lorenzo, P., Grioni, A., Quadri, M., Pedace, L., et al. (2021). Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants. BLOOD, 137(14), 1980-1984 [10.1182/blood.2020009032]. Dettaglio
  • Saettini, F., Poli, C., Vengoechea, J., Bonanomi, S., Orellana, J., Fazio, G., et al. (2021). Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency. BLOOD, 137(4), 493-499 [10.1182/blood.2020006441]. Dettaglio